Our data showed that KRAS mutations are the most common genetic alterations in Sardinian patients with lung adenocarcinoma, involving 22.1% of the cases examined and being mutually exclusive with the EGFR mutations, which were found in 12.6% of the cases studied. This evidence concerns the gene EGFR and lung adenocarcinoma.